Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Wheat sensitivity or IBS/functional dyspepsia in relatives of people with celiac disease

Official title: NCWS or IBS/FD in Relatives of CD Patients

Run by University of Palermo · NCT07584473 · Data updated 2026-11-12

This project will test whether adults related to celiac patients have higher rates of non-celiac wheat sensitivity or IBS/functional dyspepsia and whether symptoms change on a wheat-free diet.

More Celiac Disease trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment600 (estimated)
SponsorUniversity of Palermo
Academic / other
Drugs / interventionschemotherapy
Locations2 sites (Palermo, PA and 1 other locations)
StatusRecruiting
StartedApril 1, 2026
Main results expectedApril 30, 2027
Study endsApril 30, 2028
Registry record updatedMay 13, 2026
Trial IDNCT07584473 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (over 18) who are relatives (parents, grandparents, siblings, or children) of celiac disease patients, report IBS/FD-like or extraintestinal symptoms, and are willing to follow diagnostic wheat reintroduction if requested.

Probably not a fit

People with confirmed organic gastrointestinal diseases (including celiac disease or IgE-mediated wheat allergy), pregnant or breastfeeding individuals, those who already avoid wheat and refuse reintroduction, or people with recent substance abuse or recent steroid/NSAID use are unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will recruit adult relatives of celiac disease patients who report IBS/FD-like or extraintestinal symptoms and screen them for non-celiac wheat sensitivity and IBS/FD. The work combines clinical evaluation with laboratory testing (including HLA DQ2/DQ8 status, intestinal permeability, and immunologic markers), gut microbiota analysis, and duodenal biopsy when indicated. Participants will be placed on a wheat-free diet and may undergo controlled wheat reintroduction for diagnostic purposes. Study outcomes include prevalence estimates, clinical and immunological profiles, changes in intestinal permeability and microbiota, and symptom response to dietary removal of wheat.

Why it matters

Potential benefit: If successful, the project could identify relatives at higher risk for wheat-related symptoms and support targeted dietary or monitoring recommendations to reduce symptoms.

How similar studies have gone: Some prior work has shown immune or histologic gluten reactivity in relatives and identified an NCWS subgroup resembling celiac disease, but few studies have measured prevalence or tested wheat-free diets specifically in relatives.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria

* CD patient's relatives
* \>18 years old
* reporting IBS/FD-like and extraintestinal (EI) symptoms

Exclusion criteria

* self-exclusion of wheat from the diet and refuse to reintroduce it for diagnostic purposes;
* drug and/or alcohol (\>30 g/day for men and \>20 g/day for women) abuse;
* treatment with steroids and/or non-steroidal anti-inflammatory drugs in the 2 weeks before duodenal biopsy;
* pregnancy or breastfeeding;
* diagnosis of chronic inflammatory bowel disease or other organic pathologies affecting the digestive system \[e.g., IgE-mediated Wheat Allergy (WA), microscopic colitis, diverticulitis, segmental colitis associated with diverticulosis, etc.\], neurological diseases, major psychiatric disorders, infectious diseases, immunological deficiencies, and impairments limiting physical activity.

Where it's running

  • Celiac Disease and Food Intolerance Clinic, Geriatrics Unit, "P. Giaccone" University Hospital, Palermo
    Palermo, PA, Italy
    Recruiting
  • Internal Medicine Unit, P.O. "V. Cervello," Ospedali Riuniti "Villa Sofia-Cervello," Palermo
    Palermo, PA, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.